Remidio’s Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval
(Adnkronos) – World’s first Smartphone based offline AI expands geographical scope to deliver convenience and increase access to DR screening. BANGALORE, India, Feb. 23, 2023 /PRNewswire/ — Remidio has received CE mark
